Epigenomics DNA Methylation Test Successfully Detects Colorectal Cancer in Blood
19 déc. 2005 02h15 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, Dec. 19, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt:ECX) (Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced...
Ad hoc: Milestone and Licensing Decision on Tamoxifen Response Test Postponed to End of January 2006
13 déc. 2005 08h42 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, Dec. 13, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX) (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation,...
Epigenomics AG Announces End of VC Pooling
15 nov. 2005 02h37 HE
|
Epigenomics AG
BERLIN and SEATTLE, Nov. 15, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard:ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that it has...
Epigenomics AG Reports Third Quarter 2005 Financial Results
02 nov. 2005 02h38 HE
|
Epigenomics AG
SEATTLE and BERLIN, Germany, Nov. 2, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported...
Epigenomics Reports Tamoxifen Treatment Response Test Study Results Inconclusive
31 oct. 2005 02h07 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, Oct. 31, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today...
Epigenomics AG Announces Resignation of Aron Braun
12 sept. 2005 07h08 HE
|
Epigenomics AG
BERLIN, Sept. 12, 2005 (PRIMEZONE) -- Ad Hoc: Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today announced that...
Ad Hoc: Retiring Epigenomics Executive Gary Schweikhardt Released from Lock-Up at Year-End
15 août 2005 10h21 HE
|
Epigenomics AG
BERLIN, Germany and SEATTLE, Aug. 15, 2005 (PRIMEZONE) -- Epigenomics AG (Other OTC:EPGNF), a molecular diagnostics company developing tests based on DNA methylation, today announced that Morgan...
Epigenomics AG Reports Second Quarter and First Half 2005 Financial Results
03 août 2005 02h51 HE
|
Epigenomics AG
BERLIN, Aug. 3, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today reported financial results for...
Ad hoc: Epigenomics AG Announces Gary Schweikhardt to Retire
02 août 2005 14h17 HE
|
Epigenomics AG
BERLIN, Germany, Aug. 02, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, today announced that,...
Epigenomics AG Announces Second Quarter and First-Half 2005 Financial Results Conference Call
27 juil. 2005 02h39 HE
|
Epigenomics AG
BERLIN, Germany, July 27, 2005 (PRIMEZONE) -- Epigenomics AG (Frankfurt, Prime Standard: ECX), a molecular diagnostics company developing tests based on DNA methylation, announced today that it will...